Mirae Asset Global Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $660K | Sell |
|
|||||
|
2022
Q2 | $1.41M | Sell |
|
|||||
|
2022
Q1 | $2.55M | Sell |
|
|||||
|
2021
Q4 | $3.94M | Buy |
|
|||||
|
2021
Q3 | $5.74M | Sell |
|
|||||
|
2021
Q2 | $8.67M | Buy |
|
|||||
|
2021
Q1 | $1.37M | Sell |
|
|||||
|
2020
Q4 | $2.15M | Buy |
|
|||||
|
2020
Q3 | $1.35M | Buy |
|
|||||
|
2020
Q2 | $1.19M | Buy |
|
|||||
|
2020
Q1 | $1.2M | Buy |
|
|||||
|
2019
Q4 | $1.83M | Sell |
|
|||||
|
2019
Q3 | $4.12M | Buy |
|
|||||
|
2019
Q2 | $5.48M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $4.52M | Buy |
|
|||||
|
2017
Q3 | $2.83M | Buy |
|
|||||
|
2017
Q2 | $5.14M | Buy |
|